Baudax Bio is headquartered in Malvern, Pennsylvania.
Baudax Bio disclosed revenue of 1M USD for 2022 and 1M USD for 2021.
Baudax Bio has 9 employees.
Baudax Bio is a life science company.
Baudax Bio was founded in 2016.
490 Lapp Road,
Malvern, Pennsylvania
19355
United States,
(484) 395-2440
www.baudaxbio.com
Baudax Bio is a pharmaceutical company focused on innovative products for acute care and related settings. The Company has a pipeline of innovative pharmaceutical assets including two clinical-stage, novel neuromuscular blocking (NMBs) agents, one that recently completed a Phase II clinical trial and an additional unique NMB undergoing a dose escalation Phase I clinical trial, as well as a proprietary chemical reversal agent specific to these NMBs. Baudax Bio was formed in 2016 and is based in Malvern, Pennsylvania.
| Year | ≤ '18 | '19 | '20 | '21 | '22 | '23 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | - | - | - | - | 1 | 1 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
